News

As part of the negotiated settlement, the defendants paid more than $8.3 million in restitution.

The Biden administration took the first step in its Medicare drug price negotiation program for 10 of the costliest prescription drugs, giving drugmakers until March 2 to either accept the government's offer or make a counteroffer.

The Federal Trade Commission launched its inquiry of the 6 largest PBMs in June 2022, after Sen. Chuck Grassley (R-Iowa) had pressed the commission for years to review their role in determining prices for prescriptions like insulin.

After UnitedHealth recently reported 4th-quarter losses due to soaring Medicare Advantage medical costs, Humana has similarly reported steep losses, compared with a $71 million loss during the same period the previous year.

Though J&J is one of the country's largest drugmakers, the lawsuit argues, it failed to use its buying power when purchasing medications to negotiate the best prices for medicines for workers on its health plan.

The survey found that 74% of workers would consider leaving for a new role if they were offered additional education or career opportunities.